Evidence map›Paper›PMID 28678843›Full record

ArticlePLoS pathogens2017

KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation.

Roxanne C Strahan, Maria McDowell-Sargent, Timsy Uppal, Pravinkumar Purushothaman, Subhash C Verma

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Dysregulation of arginine methylation in tumorigenesis.Frontiers in molecular biosciences · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Protein arginine methylation in viral infection and antiviral immunity.International journal of biological sciences · 2023
    Review
  14. Article
  15. Histone modifiers at the crossroads of oncolytic and oncogenic viruses.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  16. Article
  17. The mRNA (New York, N.Y.) · 2021
    Article
  18. Article
  19. Protein Arginine Methyltransferase 5 FunctionsFrontiers in cell and developmental biology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Roxanne C StrahanDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States of America.ORCID http://orcid.org/0000-0002-2403-4825
Maria McDowell-SargentDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States of America.
Timsy UppalDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States of America.
Pravinkumar PurushothamanDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States of America.
Subhash C VermaDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States of America.ORCID http://orcid.org/0000-0002-0492-6578
University of Nevada, Reno · US

Funding

KSHV Lytic DNA Replication and its Control MechanismR01AI105000 · NIAID · UNIVERSITY OF NEVADA RENO · PI VERMA, SUBHASH C · 2013 to 2017
$1.8M
KSHV Genome Replication during Primary InfectionR01CA174459 · NCI · UNIVERSITY OF NEVADA RENO · PI VERMA, SUBHASH C · 2013 to 2017
$1.5M
NCI NIH HHS R01 CA174459NIAID NIH HHS R01 AI105000
6 · The paper itself

Abstract

Kaposi's sarcoma associated herpesvirus (KSHV) persists in a highly-ordered chromatin structure inside latently infected cells with the majority of the viral genome having repressive marks. However, upon reactivation the viral chromatin landscape changes into 'open' chromatin through the involvement of lysine demethylases and methyltransferases. Besides methylation of lysine residues of histone H3, arginine methylation of histone H4 plays an important role in controlling the compactness of the chromatin. Symmetric methylation of histone H4 at arginine 3 (H4R3me2s) negatively affects the methylation of histone H3 at lysine 4 (H3K4me3), an active epigenetic mark deposited on the viral chromatin during reactivation. We identified a novel binding partner to KSHV viral DNA processivity factor, ORF59-a protein arginine methyl transferase 5 (PRMT5). PRMT5 is an arginine methyltransferase that dimethylates arginine 3 (R3) of histone H4 in a symmetric manner, one hallmark of condensed chromatin. Our ChIP-seq data of symmetrically methylated H4 arginine 3 showed a significant decrease in H4R3me2s on the viral genome of reactivated cells as compared to the latent cells. Reduction in arginine methylation correlated with the binding of ORF59 on the viral chromatin and disruption of PRMT5 from its adapter protein, COPR5 (cooperator of PRMT5). Binding of PRMT5 through COPR5 is important for symmetric methylation of H4R3 and the expression of ORF59 competitively reduces the association of PRMT5 with COPR5, leading to a reduction in PRMT5 mediated arginine methylation. This ultimately resulted in a reduced level of symmetrically methylated H4R3 and increased levels of H3K4me3 marks, contributing to the formation of an open chromatin for transcription and DNA replication. Depletion of PRMT5 levels led to a decrease in symmetric methylation and increase in viral gene transcription confirming the role of PRMT5 in viral reactivation. In conclusion, ORF59 modulates histone-modifying enzymes to alter the chromatin structure during lytic reactivation.

Indexed as

Genome, ViralVirus ActivationAmino Acid MotifsArginineHerpesviridae InfectionsHerpesvirus 8, HumanHistonesHost-Pathogen InteractionsHumansMethylationArginineHistones

Identifiers

PMID28678843
PMCPMC5513536
OpenAlexW2726274361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.